580 likes | 761 Views
Objectives. Long-term pharmacotherapySmokingAlcoholOpioidsMethadoneBuprenorphineCases. Long-Term Pharmacotherapy for Substance Dependence. Doesn't cure substance dependenceHelps reduce drinking or episodes of useAchieve longer abstinenceWorks for a proportion of patientsGoalsMaintain abst
E N D
1. Medication-Assisted Therapiesfor Addiction Michael Weaver, MD, FASAM
Division of Addiction Psychiatry
Virginia Commonwealth University
Medical Center
2. Objectives Long-term pharmacotherapy
Smoking
Alcohol
Opioids
Methadone
Buprenorphine
Cases
3. Long-Term Pharmacotherapyfor Substance Dependence Doesn’t cure substance dependence
Helps reduce drinking or episodes of use
Achieve longer abstinence
Works for a proportion of patients
Goals
Maintain abstinence
Increase time to relapse
Reduce intensity of binge if relapse occurs
4. Disease Model of Addiction Biologic basis
Chronic course
Relapses and remissions
No cure
Like other chronic diseases
Treatable
Individualize therapy
Medications may help improve outcomes
5. Clinical Use of Pharmacotherapy Part of comprehensive plan that addresses psychological, social, & spiritual needs
Do not use in place of counseling
Works best in combination with psychosocial support
6. Behavioral Treatment Essential component of addiction treatment
Multiple modalities available
12-Step
Motivational Interviewing
Relapse Prevention
Contingency Management
7. Decisions, Decisions Whether to add long-term pharmacotherapy
No pharmacotherapy for most classes of abused drugs
Stimulants
Hallucinogens
Inhalants
Marijuana Factors to consider
Cost
Availability
Side effects
Barriers
Workplace drug testing
Other meds taken
Incarceration
Motivation
8. Barriers Stimatization
Science vs. dogma
Evidence-based treatment vs. “drugs for drug addicts”
12-Step groups
Becoming more progressive
Methadone Anonymous is alternative
Counselors
Different experiences and biases
Payors
May be easier to justify med than counseling
9. What is the endpoint? Duration of most long-term pharmacotherapy is not indefinite
Months to years
Goal is stabilization
Flexibility
Individualized
Allow for relapse
10. Smoking Cessation Pharmacotherapy Replacement
nicotine patches
nicotine gum
nicotine lozenges
nicotine nasal spray
Antidepressant
Zyban
Partial agonist
Varenicline (Chantix)
11. Nicotine replacement therapy Always combine with a behavioral therapy program
Most available OTC, but all are expensive
Reduces harmful effects of tobacco smoking
Patients should not smoke while using
12. Nicotine Patch Highest success rate of available pharmacotherapies
Nicoderm, Nicotrol, Habitrol, Prostep
Most come in 3 strengths: 21, 14, & 7mg
Start with 21mg patch for 6 wks, taper to 14 mg for 2 wks, finally 7 mg for 2 weeks
Use new patch in different spot on upper trunk every 24 hrs
13. Nicotine Gum Nicorette - 2 or 4mg per piece doses
Requires correct “chewing technique” -- don’t chew like regular chewing gum
Chew 1 piece for 30 minutes every 1 to 2 hrs to prevent nicotine W/D
Chew regularly for first month, then taper off over 6 months
14. Nicotine lozenges Commit, generics
Suck on & move from side to side until dissolves
4 mg or 2 mg doses
Flavor
Mint, cherry, etc.
“warming tingle”
No comparison studies with patch or gum
15. Nicotine Nasal Spray Reduces nicotine craving & mimics pleasurable effects of nicotine
1 spray in each nostril, up to 40 times in 24 hours
Use for up to 3 months
May cause tearing, sneezing, & burning sensation in nose
16. Bupropion (Zyban) Bupropion 150mg sustained release pills
Works on dopamine & norepinephrine receptors in the brain to decrease W/D
Start pills 10-14 days before “quit date”
Take daily for 3 days, then twice a day
Continue pills for 8 - 12 weeks
May cause insomnia, anxiety, or seizures
Prescription includes behavioral program
17. Varenicline (Chantix) Nicotine partial agonist
Start pills 10 days before quit date
Increase dose
Take for 12-24 weeks
Includes behavioral program
18. Pharmacotherapy forAlcohol Dependence Disulfiram (Antabuse)
Acamprosate (Campral)
Naltrexone (ReVia, Vivitrol)
19. Disulfiram (Antabuse) Blocks acetaldehyde dehydrogenase
Reaction to alcohol
Flushing, palpitations, chest tightness
Nausea, headache, anxiety
Avoid slips or relapses
Affects liver, even without alcohol
Motivation is necessary
Monitored dosing
20. Acamprosate (Campral) Alcohol dependence pharmacotherapy
No drug interactions
Minimal side effects
Diarrhea
Use caution in patients with suicidality
21. Mechanism of Action
Neurochemical mechanisms that cause relapse to alcohol have not been elucidated Acamprosate
Generally inhibitory to glutamatergic system in CNS
Probably no single definitive molecular MoA
Reduces symptoms of protracted abstinence
Insomnia
Anxiety
restlessness
22. Clinical Use of Acamprosate Begin as soon as possible after the acute withdrawal period
Does not treat withdrawal symptoms
Dose: two 333 mg tablets 3 times daily
with or without food
Takes 5-7 days to reach effective level
Treat for 12 months
Effect sustained for at least 12 months more
23. Naltrexone (ReVia) Blocks opioid receptors
Reduce craving
Tablets or implantable pellets
Reduces alcohol slips
Used for opioids as well as alcohol
24. Injectable naltrexone (Vivitrol) Intramuscular injection of depot naltrexone given monthly
Recently FDA approved for alcohol
Administer in physician office, not at home
Requires patient motivation
25. Opioid addiction treatments Ultra-rapid opioid detox
Abstinence-based
Narcotics Anonymous
Residential (with or after detox)
Antagonist maintenance
Naltrexone
Opioid maintenance
Methadone
Buprenorphine
Heroin
26. Ultra-Rapid Opioid Detox Induce acute withdrawal with naloxone
Patient under deep sedation/anesthesia
Shortens course, but still uncomfortable
High risk
High cost
Not recommended
27. Naltrexone implant Oral naltrexone compounded by pharmacy into pellet
Inserted subcutaneously (minor surgery)
Lasts for 1-3 months, may be replaced
Antagonist maintenance
Similar to oral/intramuscular naltrexone therapy
Requires detoxification from opioids first
Not approved by FDA
28. Maintenance pharmacotherapy for Opioids Long-acting medication in controlled setting
Counseling
Social services
Avoid withdrawal & craving
Reduce disease & crime
Maintenance vs. detoxification
29. Methadone Opioid substitution therapy
Harm reduction
Individual
Society
Highly regulated
Narcotic treatment programs must be licensed
Very effective
30. Mechanism of Action Methadone is a mu opioid agonist
No withdrawal symptoms
No craving
Long-acting
Multiple metabolites
Metabolized by Cytochrome P450 enzyme system
drug interactions
31. Short-term detoxification Methadone given for <180 days
Stabilization of withdrawal symptoms and behavior over weeks/months
Taper over a few months
Option for those who don’t meet criteria for maintenance
Risk of overdose after tapering off
32. Methadone maintenance Single daily dose of the long-acting opioid in a controlled setting
Use of methadone for >180 days (6 mo.)
Counseling and social services
Referral for primary medical services
33. Effectiveness Controlled trials and meta-analyses comparing medication and placebo show the superiority of agonist pharmacotherapy
Improved treatment retention
Reduces and often eliminates use of nonprescribed opioids
Decreases criminal activity
Reduces spread of HIV
Results similar to long-term therapy of most chronic diseases
34. Requirements 18 years old or older
Physical dependence
At least 1 year of use
Continuous
Intermittent
Withdrawal signs
Chronic use
Needle tracks on skin Exceptions
Younger than 18 if
Physical dependence
Failed 2 other treatments
Parental consent
Not physically dependent if just released from
Incarceration
Hospital
Pregnant
35. Blocking dose Majority of opioid receptors are blocked by methadone
No withdrawal symptoms or cravings
Can’t “feel” heroin effects
Different for each patient
Usually 60-100mg daily
May be higher for some patients
36. What is the right dose? Individually determined
Based on tolerance, withdrawal
Other medications, physical activity level
Induction
Start at 30mg and rapidly titrate up to 60mg or more
Stabilization
Client feedback, slower titration
Blind dosing
Haven’t had adequate trial of MM if hasn’t been on >60mg for several months
37. Beneficial effects Enhanced recovery
Reduced mortality
70% reduction
Overdose
Trauma
Homicide
Medical illnesses
Improved health
Medical
Psychiatric
Improved psychosocial functioning
Employment
Criminal activity
Family responsibilities
38. Side effects Sedation
Constipation
Sweating
Lower testosterone levels
Arrhythmia
Hyperalgesia
39. Does methadone get you high? No real euphoria
Onset latency
Does cause sedation
Typical opioid effects
Reassuring
Confused with “high”
Mix with other drugs
benzodiazepines
40. Driving on methadone Cognitive impairment
Induction
Change in dose
Combination with other drugs/medications
Stable dose
Safe to drive
Complex tasks
Care for others
More tickets
Less fear of police
41. Dispensing Dose set by physician
Feedback from client
Dispensed by nurse or pharmacist
Liquid or tablets
Specific procedure required
Observed dosing
Reduce diversion
Take-out doses
42. Diversion of methadone Methadone is diverted to black market
Has street value
Dosing procedure at window to reduce diversion
High security at MM clinics
Most methadone sold on street is from prescriptions for pain management, not from MM clinics
Methadone bought on street as bridge
Can’t get anything better
Trying to self-detox
43. Clinic security Alarm system
Storage safe
Surveillance
Security guards
Local police
Required by DEA
44. Counseling Required component
Formats
Groups
Individual
12-Step
Relapse prevention
Coping skills
Case management
45. Methadone forever? No federal limit for time on methadone
Some states restrict time
Virginia: evaluate every 2 years to see if can come off
Individual variability
Time required to stabilize (use, housing, family, job)
Long-term clients (decades)
Initial: can’t imagine life without something
Stable: able to consider coming off
Taper off comfortably over months/years
46. Buprenorphine Alternative to methadone for opioid addiction treatment
Long-acting opioid agonist-antagonist
Multiple forms available
Combined with naloxone (Suboxone): most common
Buprenorphine only (Subutex)
Used for treatment of acute pain (Buprenex)
Detox or maintenance
47. Buprenorphine Binds to opioid receptors in body
Only activates receptor around 40%, not 100% like other opioids (heroin, methadone)
If already in withdrawal, 40% is pretty good
If not in withdrawal, dropping from 100% to 40% receptor activation causes withdrawal
Very low risk of overdose
Can OD when combined with sedative (benzos)
48. Buprenorphine/naloxone Combination helps reduce abuse
Naloxone only active when Suboxone is injected
Results in withdrawal for users trying to get high
Bup alone has similar effect when injected by those who are opioid dependent and not in withdrawal already
49. Office-based opioid therapy Buprenorphine is less restricted than methadone (Schedule III)
Get prescription from pharmacy with refills (up to 6 months)
Outpatient physician visits for medication checks as needed
Addiction counseling is separate, patient may be referred to another provider for this service
50. Taking buprenorphine Sublingual tablet
Dissolve under tongue
Takes around 5 min. to dissolve
Won’t be active if swallowed
Comes in 2mg and 8mg tablets
Typical dose is 12-16 mg once daily
Can take 3 times a week
51. Methadone or Buprenorphine? Treatment efficacy equivalent
Similar opioid side effects
Abuse potential
Slightly higher for buprenorphine in opioid non-dependent persons
Buprenorphine has fewer drug interactions
Methadone has no ceiling effect
Buprenorphine more convenient (less restricted)
Methadone less expensive
Higher cost of buprenorphine, counseling separate cost
Buprenorphine not age-restricted (can use in teens)
Individual decision
52. Dealing with other drug use In general, all drug use is reduced on MM & bup
May escalate other drug use when heroin not effective
Cocaine
Alcohol
Sedatives (benzos)
Intensify counseling, reaffirm goals for all drug abstinence
53. Monitoring for relapse Patient report
Clinical observation
Collateral information
Family
Other counselors
Probation officer
Urine drug screening
54. Urine drug screening Use as deterrent, not to ‘catch in the act’
Random
Minimum of 8 samples/year on maintenance therapy
Verify presence of methadone, buprenorphine, etc.
Look for
Illicit substances
Unauthorized prescriptions
Opioids
Benzodiazepines
55. Summary Long-term pharmacotherapy is available and effective for several addictions
Medication + counseling = recovery
Smoking cessation
Nicotine replacement is available over-the-counter
Bupropion and varenicline are available by prescription for smoking cessation
Multiple medications are available by prescription for alcohol dependence
56. Summary Methadone/buprenorphine maintenance proven to reduce mortality, crime, & spread of infection
Substitution therapy to eliminate withdrawal, cravings, & heroin effects
Individualized dose and time on maintenance
Effective for more than just opioid addiction
57. Questions?
58. Cases for Group Discussion